175 related articles for article (PubMed ID: 28214152)
1. Clinical and genetic diagnosis of familial hypertrophic cardiomyopathy: Results in pediatric cardiology.
Cardoso B; Gomes I; Loureiro P; Trigo C; Ferreira Pinto F
Rev Port Cardiol; 2017 Mar; 36(3):155-165. PubMed ID: 28214152
[TBL] [Abstract][Full Text] [Related]
2. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
[TBL] [Abstract][Full Text] [Related]
4. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Axelsson A; Køber L; Bundgaard H
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1511-8. PubMed ID: 26231341
[TBL] [Abstract][Full Text] [Related]
6. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant.
Lorca R; Gómez J; Martín M; Cabanillas R; Calvo J; León V; Pascual I; Morís C; Coto E; R Reguero JJ
Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):138-144. PubMed ID: 29631964
[TBL] [Abstract][Full Text] [Related]
7. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
[TBL] [Abstract][Full Text] [Related]
8. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
[TBL] [Abstract][Full Text] [Related]
9. A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report.
Gao G; Liu G; Chen W; Tong Y; Mao C; Liu J; Zhang X; He MM; Yang P
Medicine (Baltimore); 2020 Aug; 99(34):e21843. PubMed ID: 32846832
[TBL] [Abstract][Full Text] [Related]
10. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
[TBL] [Abstract][Full Text] [Related]
11. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.
Christiaans I; Birnie E; Bonsel GJ; Mannens MM; Michels M; Majoor-Krakauer D; Dooijes D; van Tintelen JP; van den Berg MP; Volders PG; Arens YH; van den Wijngaard A; Atsma DE; Helderman-van den Enden AT; Houweling AC; de Boer K; van der Smagt JJ; Hauer RN; Marcelis CL; Timmermans J; van Langen IM; Wilde AA
Eur Heart J; 2011 May; 32(9):1161-70. PubMed ID: 21459882
[TBL] [Abstract][Full Text] [Related]
12. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.
Fujita E; Nakanishi T; Nishizawa T; Hagiwara N; Matsuoka R
Heart Vessels; 2013 Nov; 28(6):785-94. PubMed ID: 23494605
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
[TBL] [Abstract][Full Text] [Related]
15. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy.
Ingles J; McGaughran J; Scuffham PA; Atherton J; Semsarian C
Heart; 2012 Apr; 98(8):625-30. PubMed ID: 22128210
[TBL] [Abstract][Full Text] [Related]
17. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
[TBL] [Abstract][Full Text] [Related]
18. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Maron BJ; Maron MS; Semsarian C
J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
[TBL] [Abstract][Full Text] [Related]
20. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
